Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
President Donald Trump has consistently demonstrated a preference for maintaining control over escalation rather than allowing events to dictate American strategy.
The economic liberalism that the world took for granted has given way to the White House’s attempt to gain sectarian control over institutions, as well as government intervention into private companies,